Molecular Partners AG Reports Acceptable Safety Profile and Initial Efficacy Data for MP0533 and MP0621 at ASH 2024
Molecular Partners updates on MP0533 and MP0621 studies, showing acceptable safety and initial efficacy in ongoing clinical trials.Quiver AI SummaryMolecular Partners AG announced continued progress in...